Chrysin restores PDGF-induced inhibition on protein tyrosine phosphatase and reduces PDGF signaling in cultured VSMCs

Journal of Nutritional Biochemistry

Volumn 23, Issue 6, 2012, Pages 667-678

  Lo, Huey Ming ^a,b   Wu, Min Wen ^c   Pan, Shiow Lin ^d   Peng, Chieh Yu ^e,f   Wu, Pi Hui ^a   Wu, Wen Bin ^a  

^a FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^b SHIN KONG WU HO SU MEMORIAL HOSPITAL   (Taiwan)

^c TAO YUAN GENERAL HOSPITAL   (Taiwan)

^d NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^e CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^f CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Flavonoid; Migration; Neointima; PTP; Vascular smooth muscle cell

Indexed keywords

ACETYLCYSTEINE; CHRYSIN; CYSTEINE; EPIGALLOCATECHIN GALLATE; GLUTAREDOXIN; GLUTATHIONE; HYDROGEN PEROXIDE; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR RECEPTOR; PROTEIN TYROSINE PHOSPHATASE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; VANADIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERY; ARTICLE; ATTENUATION; AUTOPHOSPHORYLATION; CAROTID ANGIOPLASTY; CAROTID ARTERY INJURY; CELL CULTURE; CELL PROLIFERATION; CHEMOTAXIS; CONTROLLED STUDY; DRUG EFFICACY; DRUG INHIBITION; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME METABOLISM; IN VITRO STUDY; IN VIVO STUDY; INTRACELLULAR MEMBRANE; LOW DRUG DOSE; NEOINTIMA; NONHUMAN; OXIDATION REDUCTION STATE; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DEPLETION; PROTEIN FUNCTION; PROTEIN INDUCTION; RAT; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE; VASCULAR SMOOTH MUSCLE CELL;

ACETYLCYSTEINE; ADMINISTRATION, ORAL; ANIMALS; ANTIOXIDANTS; CATECHIN; CELL PROLIFERATION; FLAVONOIDS; GLUTATHIONE; HYDROGEN PEROXIDE; HYPERPLASIA; MUSCLE, SMOOTH, VASCULAR; NADPH OXIDASE; NEOINTIMA; PHOSPHORYLATION; PLATELET-DERIVED GROWTH FACTOR; PROTEIN TYROSINE PHOSPHATASES; RATS; REACTIVE OXYGEN SPECIES; RECEPTORS, PLATELET-DERIVED GROWTH FACTOR; SIGNAL TRANSDUCTION; TUNICA INTIMA; VANADATES;

RATTUS;

EID: 84860884033     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2011.03.011     Document Type: Article

References (46)

1. Raines E.W. PDGF and cardiovascular disease. Cytokine Growth Factor Rev 2004, 15:237-254.
2. Barrett T.B., Benditt E.P. sis (platelet-derived growth factor B chain) gene transcript levels are elevated in human atherosclerotic lesions compared to normal artery. Proc Natl Acad Sci U S A 1987, 84:1099-1103.
3. Barrett T.B., Benditt E.P. Platelet-derived growth factor gene expression in human atherosclerotic plaques and normal artery wall. Proc Natl Acad Sci U S A 1988, 85:2810-2814.
4. Tanizawa S., Ueda M., van der Loos C.M., van der Wal A.C., Becker A.E. Expression of platelet derived growth factor B chain and beta receptor in human coronary arteries after percutaneous transluminal coronary angioplasty: an immunohistochemical study. Heart 1996, 75:549-556.
5. Ueda M., Becker A.E., Kasayuki N., Kojima A., Morita Y., Tanaka S. In situ detection of platelet-derived growth factor-A and -B chain mRNA in human coronary arteries after percutaneous transluminal coronary angioplasty. Am J Pathol 1996, 149:831-843.
6. Heldin C.H., Ostman A., Ronnstrand L. Signal transduction via platelet-derived growth factor receptors. Biochim Biophys Acta 1998, 1378:F79-F113.
7. Tallquist M., Kazlauskas A. PDGF signaling in cells and mice. Cytokine Growth Factor Rev 2004, 15:205-213.
8. Sundaresan M., Yu Z.X., Ferrans V.J., Irani K., Finkel T. Requirement for generation of H2O2 for platelet-derived growth factor signal transduction. Science 1995, 270:296-299.
9. Finkel T. Oxidant signals and oxidative stress. Curr Opin Cell Biol 2003, 15:247-254.
10. Lambeth J.D. NOX enzymes and the biology of reactive oxygen. Nat Rev Immunol 2004, 4:181-189.
11. Rhee S.G., Kang S.W., Jeong W., Chang T.S., Yang K.S., Woo H.A. Intracellular messenger function of hydrogen peroxide and its regulation by peroxiredoxins. Curr Opin Cell Biol 2005, 17:183-189.
12. Tonks N.K. Protein tyrosine phosphatases: from genes, to function, to disease. Nat Rev Mol Cell Biol 2006, 7:833-846.
13. Fiaschi T., Chiarugi P., Buricchi F., Giannoni E., Taddei M.L., Talini D., et al. Low Molecular Weight Protein-tyrosine Phosphatase Is Involved in Growth Inhibition during Cell Differentiation. J Biol Chem 2001, 276:49156-49163.
14. Kappert K., Peters K.G., Bohmer F.D., Ostman A. Tyrosine phosphatases in vessel wall signaling. Cardiovasc Res 2005, 65:587-598.
15. Kappert K., Paulsson J., Sparwel J., Leppanen O., Hellberg C., Ostman A., et al. Dynamic changes in the expression of DEP-1 and other PDGF receptor-antagonizing PTPs during onset and termination of neointima formation. FASEB J 2007, 21:523-534.
16. Kappert K., Sparwel J., Sandin A., Seiler A., Siebolts U., Leppanen O., et al. Antioxidants relieve phosphatase inhibition and reduce PDGF signaling in cultured VSMCs and in restenosis. Arterioscler Thromb Vasc Biol 2006, 26:2644-2651.
17. Knekt P., Kumpulainen J., Jarvinen R., Rissanen H., Heliovaara M., Reunanen A., et al. Flavonoid intake and risk of chronic diseases. Am J Clin Nutr 2002, 76:560-568.
18. Arts I.C., Hollman P.C. Polyphenols and disease risk in epidemiologic studies. Am J Clin Nutr 2005, 81:317S-325S.
19. Duarte J., Jimenez R., Villar I.C., Perez-Vizcaino F., Jimenez J., Tamargo J. Vasorelaxant effects of the bioflavonoid chrysin in isolated rat aorta. Planta Med 2001, 67:567-569.
20. Villar I.C., Galisteo M., Vera R., O'Valle F., Garcia-Saura M.F., Zarzuelo A., et al. Effects of the dietary flavonoid chrysin in isolated rat mesenteric vascular bed. J Vasc Res 2004, 41:509-516.
21. Villar I.C., Vera R., Galisteo M., O'Valle F., Romero M., Zarzuelo A., et al. Endothelial nitric oxide production stimulated by the bioflavonoid chrysin in rat isolated aorta. Planta Med 2005, 71:829-834.
22. Hecker M., Preiss C., Schini-Kerth V.B., Busse R. Antioxidants differentially affect nuclear factor kappa B-mediated nitric oxide synthase expression in vascular smooth muscle cells. FEBS Lett 1996, 380:224-228.
23. Lo H.M., Hung C.F., Tseng Y.L., Chen B.H., Jian J.S., Wu W.B. Lycopene binds PDGF-BB and inhibits PDGF-BB-induced intracellular signaling transduction pathway in rat smooth muscle cells. Biochem Pharmacol 2007, 74:54-63.
24. Sharma P., Chakraborty R., Wang L., Min B., Tremblay M.L., Kawahara T., et al. Redox regulation of interleukin-4 signaling. Immunity 2008, 29:551-564.
25. Persson C., Sjoblom T., Groen A., Kappert K., Engstrom U., Hellman U., et al. Preferential oxidation of the second phosphatase domain of receptor-like PTP-alpha revealed by an antibody against oxidized protein tyrosine phosphatases. Proc Natl Acad Sci U S A 2004, 101:1886-1891.
26. Huyer G., Liu S., Kelly J., Moffat J., Payette P., Kennedy B., et al. Mechanism of Inhibition of Protein-tyrosine Phosphatases by Vanadate and Pervanadate. J Biol Chem 1997, 272:843-851.
27. Peng C.Y., Pan S.L., Guh J.H., Liu Y.N., Chang Y.L., Kuo S.C., et al. The indazole derivative YD-3 inhibits thrombin-induced vascular smooth muscle cell proliferation and attenuates intimal thickening after balloon injury. Thromb Haemost 2004, 92:1232-1239.
28. Weber A.A., Neuhaus T., Skach R.A., Hescheler J., Ahn H.Y., Schror K., et al. Mechanisms of the inhibitory effects of epigallocatechin-3 gallate on platelet-derived growth factor-BB-induced cell signaling and mitogenesis. FASEB J 2004, 18:128-130.
29. Saito S., Frank G.D., Mifune M., Ohba M., Utsunomiya H., Motley E.D., et al. Ligand-independent trans-activation of the platelet-derived growth factor receptor by reactive oxygen species requires protein kinase C-delta and c-Src. J Biol Chem 2002, 277:44695-44700.
30. Maejima Y., Kuroda J., Matsushima S., Ago T., Sadoshima J. Regulation of myocardial growth and death by NADPH oxidase. J Mol Cell Cardiol 2011, 50:408-416.
31. Denu J.M., Lohse D.L., Vijayalakshmi J., Saper M.A., Dixon J.E. Visualization of intermediate and transition-state structures in protein-tyrosine phosphatase catalysis. Proc Natl Acad Sci U S A 1996, 93:2493-2498.
32. Chiarugi P., Fiaschi T., Taddei M.L., Talini D., Giannoni E., Raugei G., et al. Two vicinal cysteines confer a peculiar redox regulation to low molecular weight protein tyrosine phosphatase in response to platelet-derived growth factor receptor stimulation. J Biol Chem 2001, 276:33478-33487.
33. Barrett W.C., DeGnore J.P., Konig S., Fales H.M., Keng Y.F., Zhang Z.Y., et al. Regulation of PTP1B via Glutathionylation of the Active Site Cysteine 215. Biochemistry 1999, 38:6699-6705.
34. Kanda M., Ihara Y., Murata H., Urata Y., Kono T., Yodoi J., et al. Glutaredoxin Modulates Platelet-derived Growth Factor-dependent Cell Signaling by Regulating the Redox Status of Low Molecular Weight Protein-tyrosine Phosphatase. J Biol Chem 2006, 281:28518-28528.
35. Kim J.H., Jin Y.R., Park B.S., Kim T.J., Kim S.Y., Lim Y., et al. Luteolin prevents PDGF-BB-induced proliferation of vascular smooth muscle cells by inhibition of PDGF beta-receptor phosphorylation. Biochem Pharmacol 2005, 69:1715-1721.
36. Kim S.Y., Jin Y.R., Lim Y., Kim J.H., Cho M.R., Hong J.T., et al. Inhibition of PDGF beta-receptor tyrosine phosphorylation and its downstream intracellular signal transduction in rat aortic vascular smooth muscle cells by kaempferol. Planta Med 2005, 71:599-603.
37. Ahn H.Y., Hadizadeh K.R., Seul C., Yun Y.P., Vetter H., Sachinidis A. Epigallocathechin-3 Gallate Selectively Inhibits the PDGF-BB-induced Intracellular Signaling Transduction Pathway in Vascular Smooth Muscle Cells and Inhibits Transformation of sis-transfected NIH 3T3 Fibroblasts and Human Glioblastoma Cells (A172). Mol Biol Cell 1999, 10:1093-1104.
38. Balavenkatraman K.K., Jandt E., Friedrich K., Kautenburger T., Pool-Zobel B.L., Ostman A., et al. DEP-1 protein tyrosine phosphatase inhibits proliferation and migration of colon carcinoma cells and is upregulated by protective nutrients. Oncogene 2006, 25:6319-6324.
39. Hertog J.D., Ostman A., Bohmer F.-D. Protein tyrosine phosphatases: regulatory mechanisms. FEBS J 2008, 275:831-847.
40. Shih P.H., Yeh C.T., Yen G.C. Anthocyanins Induce the Activation of Phase II Enzymes through the Antioxidant Response Element Pathway against Oxidative Stress-Induced Apoptosis. J Agric Food Chem 2007, 55:9427-9435.
41. Robaszkiewicz A., Balcerczyk A., Bartosz G. Antioxidative and prooxidative effects of quercetin on A549 cells. Cell Biol Int 2007, 31:1245-1250.
42. Sathiavelu J., Senapathy G.J., Devaraj R., Namasivayam N. Hepatoprotective effect of chrysin on prooxidant-antioxidant status during ethanol-induced toxicity in female albino rats. J Pharm Pharmacol 2009, 61:809-817.
43. Ramos A.M., Aller P. Quercetin decreases intracellular GSH content and potentiates the apoptotic action of the antileukemic drug arsenic trioxide in human leukemia cell lines. Biochem Pharmacol 2008, 75:1912-1923.
44. Persson C., Kappert K., Engstrom U., Ostman A., Sjoblom T. An antibody-based method for monitoring in vivo oxidation of protein tyrosine phosphatases. Methods 2005, 35:37-43.
45. Thomasset S.C., Berry D.P., Garcea G., Marczylo T., Steward W.P., Gescher A.J. Dietary polyphenolic phytochemicals. Promising cancer chemopreventive agents in humans? A review of their clinical properties. Int J Cancer 2007, 120:451-458.
46. Yang C.S., Maliakal P., Meng X. Inhibition of carcinogenesis by tea. Annu Rev Pharmacol Toxicol 2002, 42:25-54.